Prawo i regulacje · 10/01/2014

Myoderm Seeks FDA Approval to Import Controlled Substance

The U.S. government has issued a notice of application for Myoderm, a pharmaceutical company, to import a controlled substance. The application is related to Myoderm's proposal to manufacture and distribute the substance, which is subject to strict regulations under the Controlled Substances Act.